EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H19N3O |
| Net Charge | 0 |
| Average Mass | 293.370 |
| Monoisotopic Mass | 293.15281 |
| SMILES | Cc1ncnc1C[C@H]1CCc2c(C)c3ccccc3n2C1=O |
| InChI | InChI=1S/C18H19N3O/c1-11-14-5-3-4-6-17(14)21-16(11)8-7-13(18(21)22)9-15-12(2)19-10-20-15/h3-6,10,13H,7-9H2,1-2H3,(H,19,20)/t13-/m1/s1 |
| InChIKey | AEKQMJRJRAHOAP-CYBMUJFWSA-N |
| Roles Classification |
|---|
| Biological Role: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. |
| Applications: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fabesetron (CHEBI:31588) has role antiemetic (CHEBI:50919) |
| fabesetron (CHEBI:31588) has role serotonergic antagonist (CHEBI:48279) |
| fabesetron (CHEBI:31588) is a imidazoles (CHEBI:24780) |
| fabesetron (CHEBI:31588) is a organic heterotricyclic compound (CHEBI:26979) |
| IUPAC Name |
|---|
| (7R)-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one |
| INNs | Source |
|---|---|
| fabesetron | WHO MedNet |
| fabesetrón | WHO MedNet |
| fabésétron | WHO MedNet |
| fabesetronum | WHO MedNet |
| Synonyms | Source |
|---|---|
| FK 1052 | ChEBI |
| FK-1052 | ChEBI |
| FK1052 | ChEBI |
| (+)-(R)-8,9-dihydro-10-methyl-7-((5-methylimidazol-4-yl)methyl)pyrido[1,2-a]indol-6(7H)-one | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| CAS:129300-27-2 | ChemIDplus |
| Citations |
|---|